Literature DB >> 23692951

Endogenous A1 adenosine receptor protects mice from acute ethanol-induced hepatotoxicity.

Ping Yang1, Zhongqiu Wang, Yibei Zhan, Tao Wang, Mengyi Zhou, Lin Xia, Xiao Yang, Jianfa Zhang.   

Abstract

Previous studies have indicated a critical role of adenosine and its receptors in the pathogenesis of liver diseases. The aim of this study was to determine the contribution of A1 adenosine receptor (A1AR) to acute ethanol-induced hepatotoxicity. Wild-type (WT) and A1AR(-/-) mice were intragastrically administered with ethanol (5 g/kg), and hepatic injury was evaluated 6h thereafter. Mice lacking A1AR were more susceptible to ethanol-induced liver damage than WT mice, as evidenced by higher serum transaminase levels and increased extent of histopathological changes. Ethanol induced triglycerides accumulation in the serum and liver, and this accumulation was augmented in A1AR(-/-) mice. Analysis of gene expression in the liver revealed up-regulated mRNA levels of genes related to lipogenesis (including: FAS, SCD1, ACC1, DGAT2, and PPARγ) in A1AR(-/-) mice after ethanol treatment. In addition, lack of A1AR aggravated lipid peroxidation and superoxide dismutase depletion caused by acute ethanol exposure. A subsequent study revealed that, pretreatment with A1AR antagonist DPCPX increases the sensitivity of mice to ethanol-induced liver injury. In conclusion, these results indicated that endogenous A1AR activation protects mice against acute ethanol-induced liver injury by reducing oxidative stress and decreasing lipid accumulation.
Copyright © 2013. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23692951     DOI: 10.1016/j.tox.2013.05.003

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  8 in total

Review 1.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 2.  Purinergic signaling in hepatic disease.

Authors:  E Velázquez-Miranda; M Díaz-Muñoz; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2019-10-01       Impact factor: 3.765

3.  Mildly compromised tetrahydrobiopterin cofactor biosynthesis due to Pts variants leads to unusual body fat distribution and abdominal obesity in mice.

Authors:  Germaine Korner; Tanja Scherer; Dea Adamsen; Alexander Rebuffat; Mark Crabtree; Anahita Rassi; Rossana Scavelli; Daigo Homma; Birgit Ledermann; Daniel Konrad; Hiroshi Ichinose; Christian Wolfrum; Marion Horsch; Birgit Rathkolb; Martin Klingenspor; Johannes Beckers; Eckhard Wolf; Valérie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Nenad Blau; Jan Rozman; Beat Thöny
Journal:  J Inherit Metab Dis       Date:  2016-02-01       Impact factor: 4.982

Review 4.  Purinergic signalling in the liver in health and disease.

Authors:  Geoffrey Burnstock; Byron Vaughn; Simon C Robson
Journal:  Purinergic Signal       Date:  2013-11-24       Impact factor: 3.765

Review 5.  I drink for my liver, Doc: emerging evidence that coffee prevents cirrhosis.

Authors:  Jordan J Feld; Élise G Lavoie; Michel Fausther; Jonathan A Dranoff
Journal:  F1000Res       Date:  2015-04-21

6.  A novel antioxidant multitarget iron chelator M30 protects hepatocytes against ethanol-induced injury.

Authors:  Jia Xiao; Yi Lv; Bin Lin; George L Tipoe; Moussa B H Youdim; Feiyue Xing; Yingxia Liu
Journal:  Oxid Med Cell Longev       Date:  2015-02-04       Impact factor: 6.543

7.  Hepatoprotective effects of hoveniae semen cum fructus extracts in ethanol intoxicated mice.

Authors:  Ilje Cho; Joowan Kim; Jaijun Jung; Soohyun Sung; Jongkyu Kim; Namju Lee; Saekwang Ku
Journal:  J Exerc Nutrition Biochem       Date:  2016-03-31

8.  Xanthohumol, a prenylated flavonoid from hops (Humulus lupulus L.), protects rat tissues against oxidative damage after acute ethanol administration.

Authors:  Carmen Pinto; Juan J Cestero; Beatriz Rodríguez-Galdón; Pedro Macías
Journal:  Toxicol Rep       Date:  2014-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.